While IL-17 is essential for defending against extracellular pathogens such as bacteria and fungi, its dysregulation has been implicated in a range of inflammatory and autoimmune diseases, including psoriasis, rheumatoid arthritis, and inflammatory bowel disease. Here, IL17A is linked to rheumatoid arthritis.